ArticleNeurogastroenterology and motility2026
Beyond Malabsorption: The Need for Symptom-Based Assessment in Suspected Lactose Intolerance. Lessons From a Test-Specific Symptom Assessment.
Article in Neurogastroenterology and motility, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLactose malabsorption is commonly assumed to cause gastrointestinal discomfort, but symptoms often persist despite lactose restriction or enzyme supplementation.
objectiveThis study aimed to assess symptoms following lactose ingestion, its relationship with malabsorption, and its association with fructose sensitivity and disorders of the gut-brain interactions (DGBIs).
designIn 753 consecutive patients with DGBIs, we performed hydrogen breath tests and used the validated adult Carbohydrate Perception Questionnaire (aCPQ) to assess lactose-induced symptoms. Lactose malabsorption (LM+) was defined as a hydrogen increase of > 20 ppm. Lactose induced burdensome symptoms (LS+) were defined by a visual analogue scale (VAS) increase of > 20 mm. Fructose sensitivity was assessed in 547 patients using the same protocol.
resultsLM+ was observed in 40.9% of patients, while 55.4% reported LS+. Interestingly, 45.3% of symptomatic patients had no lactose malabsorption (LM-) and 26.0% of malabsorbers had no symptoms (LS-). LS+ were significantly more likely to exhibit fructose sensitivity (45.2% vs. 24.2% in LS-, p < 0.001). DGBIs were similarly distributed in LS+ patients with and without malabsorption. Functional dyspepsia and irritable bowel syndrome were significantly more frequent in LS+, irrespective of whether lactose was malabsorbed or not, than in those without lactose-induced symptoms (with or without malabsorption).
conclusionLactose malabsorption alone is an inadequate predictor of the occurrence of symptoms, emphasizing the need for comprehensive symptom assessment beyond breath test results. This has important implications for the selection of appropriate therapies. The association between lactose and fructose sensitivity suggests a role for visceral hypersensitivity and overlapping mechanisms in symptom development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.